Omeros Corp. PT Raised to $32.00 at Wedbush (OMER)
Wedbush lifted their price objective on shares of Omeros Corp. (NASDAQ:OMER) to $32.00 in a research note issued on Wednesday, Stock Ratings Network.com reports. Wedbush’s target price suggests a potential upside of 230.58% from the company’s current price.
Shares of Omeros Corp. (NASDAQ:OMER) traded up 16.74% on Wednesday, hitting $11.30. The stock had a trading volume of 1,361,975 shares. Omeros Corp. has a one year low of $3.65 and a one year high of $11.85. The stock’s 50-day moving average is $6.36 and its 200-day moving average is $5.27. The company’s market cap is $337.3 million.
Omeros Corp. (NASDAQ:OMER) last announced its earnings results on Friday, August 9th. The company reported ($0.48) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by $0.10. The company had revenue of $0.14 million for the quarter, compared to the consensus estimate of $1.19 million. During the same quarter in the previous year, the company posted ($0.38) earnings per share. The company’s revenue for the quarter was down 90.8% on a year-over-year basis. On average, analysts predict that Omeros Corp. will post $-1.72 earnings per share for the current fiscal year.
Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.